Industry Overview

tissue banking market was valued at $3.1 billion in 2025 and is projected to reach $6.2 billion by 2035, growing at a CAGR of 7.2% from 2026 to 2035. The expansion of this market is being supported by increasing demand for advanced preservation techniques and reliable storage systems across clinical and research settings. Growing emphasis on maintaining biological sample integrity for extended durations has led to higher adoption of specialized equipment and preservation media. In addition, continuous improvements in cryogenic technologies and standardized handling protocols are enhancing operational efficiency and consistency. The rising volume of biomedical research activities, particularly in regenerative medicine and translational studies, is further contributing to sustained product demand. Furthermore, regulatory focus on quality assurance and traceability is encouraging institutions to invest in validated and compliant solutions. Collectively, these factors are reinforcing steady growth in the market.

Market Dynamics

Advancement in Cryopreservation Technologies

Ongoing advancements in cryopreservation technologies are significantly influencing the market landscape. Innovations in controlled-rate freezing, vitrification methods, and improved preservation media are enhancing the viability and integrity of stored tissues. These developments are enabling more reliable long-term storage while minimizing cellular damage. Manufacturers are increasingly focusing on precision-driven equipment to meet stringent quality standards in clinical and research applications. Additionally, automation and monitoring capabilities are being integrated to ensure consistency and reduce manual intervention. Such technological progress is strengthening confidence among end users and supporting broader adoption.

Rising Demand from Regenerative Medicine and Research Applications

The growing focus on regenerative medicine and translational research is driving demand for tissue banking products. Increasing use of preserved tissues in areas such as oncology, orthopaedics, and stem cell research is expanding the application base. Research institutions and healthcare organizations are investing in advanced storage solutions to support ongoing studies and clinical trials. This demand is further supported by the need for high-quality biological samples to ensure accurate outcomes. As research activities continue to expand globally, the requirement for efficient preservation and storage systems is expected to remain strong. These trends collectively contribute to sustained market growth.

Market Segmentation

• Based on the products, the market is segmented into equipment and consumables & media.
• Based on the applications, the market is segmented into medical research, therapeutics, and others.

Equipment Segment to Lead the Market with the Largest Share

 The equipment segment continues to expand steadily, supported by increasing adoption of advanced cryogenic storage systems and controlled-rate freezers across biobanks and clinical facilities. Demand is being driven by the need for precise temperature management and long-term preservation reliability, particularly in regulated environments. Leading manufacturers such as Thermo Fisher Scientific Inc, PHC Holdings Corporation, and Chart Industries Inc are strengthening their portfolios with technologically advanced and energy-efficient systems. Recent developments highlight a shift toward automation, real-time monitoring, and integrated data tracking capabilities to improve operational control. Institutions are also prioritizing scalable infrastructure to accommodate growing sample volumes. These factors are collectively reinforcing sustained demand for high-value equipment solutions.

Therapeutics: A Key Segment in Market Growth

 The therapeutics segment is gaining traction due to the increasing clinical use of preserved tissues in treatment procedures and regenerative applications. Growth is supported by rising adoption in areas such as oncology, orthopedics, and reconstructive therapies, where high-quality biological materials are essential. Companies, including BioLife Solutions Inc, Lonza Group AG, and Merck KGaA, are actively enhancing their preservation media and solutions tailored for clinical-grade use. Recent trends indicate a growing emphasis on compliance with stringent regulatory standards and validated preservation protocols. Healthcare providers are investing in reliable storage and handling systems to ensure treatment efficacy and patient safety. This evolving clinical landscape continues to create consistent demand within the segment.

Regional Outlook

The global tissue banking market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Region Dominates the Market with Major Share

North America continues to hold the largest share of the market, supported by a well-established healthcare infrastructure and a strong network of accredited tissue banks. The region benefits from high adoption of advanced preservation technologies and increasing use of stored tissues in clinical procedures. Companies such as Thermo Fisher Scientific Inc, Merck KGaA, and Avantor Inc maintain a strong presence through continuous product innovation and distribution capabilities. Recent developments show increasing integration of automation and digital monitoring systems to improve traceability and compliance. Growth is further reinforced by rising cases of chronic diseases and growing demand for transplant procedures. The presence of strict regulatory frameworks also ensures consistent quality standards, strengthening market maturity.

Asia-Pacific to Witness as a Fastest Growing Region

Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare infrastructure and rising investment in biomedical research. Increasing awareness of tissue preservation and growing demand for advanced medical treatments are supporting market expansion. Key players such as PHC Holdings Corporation, Eppendorf SE, and local manufacturers are expanding their footprint through regional partnerships and distribution networks. Recent trends indicate a rise in private and hospital-based tissue banking facilities, improving accessibility and turnaround times. Governments across the region are also encouraging biobanking initiatives and research collaborations. These developments are collectively accelerating adoption and positioning the region for sustained high growth.

Market Players Outlook

The major companies operating in the global tissue banking market include Thermo Fisher Scientific Inc., Merck KGaA, Avantor Inc., Sartorius AG, and Agilent Technologies Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In February 2026, Cryoport Inc., through its MVE Biological Solutions division, launched the Fusion 800 Series cryogenic freezer, a self-sustaining system designed for tissue banks and biorepositories that eliminates the need for continuous liquid nitrogen supply while maintaining temperatures at or below ?150°C, improving operational efficiency and storage reliability in space-constrained environments.

• In April 2024, Thermo Fisher Scientific Inc introduced the TSX Universal Series ultra-low temperature freezers, designed to enhance cold storage reliability for biological samples, including tissues, with improved temperature control and faster recovery performance.

The Report Covers

• Market value data analysis for 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global tissue banking market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.